{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:59Z","timestamp":1793600879043,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.diabres.2026.113166","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:20:27Z","timestamp":1771374027000},"page":"113166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Precision staging of Type 2 diabetes through Hypergraph-Based multimorbidity Profiling: From hepatic disruption to cardiovascular escalation"],"prefix":"10.1016","volume":"235","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9228-276X","authenticated-orcid":false,"given":"Xia","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113166_b0005","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, https:\/\/diabetesatlas.org; 2025 [accessed 18 August 2025]."},{"issue":"7","key":"10.1016\/j.diabres.2026.113166_b0010","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1185\/03007995.2016.1168291","article-title":"Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus","volume":"32","author":"Iglay","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.diabres.2026.113166_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1362433","article-title":"Prevalence and co-prevalence of comorbidities among chinese adult patients with type 2 diabetes mellitus: a cross-sectional, multicenter, retrospective, observational study based on 3B study database","volume":"15","author":"Ji","year":"2024","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.diabres.2026.113166_b0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1077558711399580","article-title":"Review: health care utilization and costs of elderly persons with multiple chronic conditions","volume":"68","author":"Lehnert","year":"2011","journal-title":"Med Care Res Rev"},{"issue":"3","key":"10.1016\/j.diabres.2026.113166_b0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ecl.2021.05.012","article-title":"Characterizing Multimorbidity from Type 2 Diabetes: Insights from Clustering Approaches","volume":"50","author":"Cicek","year":"2021","journal-title":"Endocrin Metab Clin"},{"issue":"11","key":"10.1016\/j.diabres.2026.113166_b0030","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1177\/00220345221098910","article-title":"Systemic Multimorbidity Clusters in people with Periodontitis","volume":"101","author":"Larvin","year":"2022","journal-title":"J Dent Res"},{"issue":"1","key":"10.1016\/j.diabres.2026.113166_b0035","doi-asserted-by":"crossref","first-page":"14567","DOI":"10.1038\/s41598-019-51135-7","article-title":"Investigation of multimorbidity and prevalent disease combinations in older irish adults using network analysis and association rules","volume":"9","author":"Hernandez","year":"2019","journal-title":"Sci Rep-Uk"},{"issue":"10","key":"10.1016\/j.diabres.2026.113166_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107979","article-title":"A network-based study reveals multimorbidity patterns in people with type 2 diabetes","volume":"26","author":"Zhang","year":"2023","journal-title":"Iscience"},{"key":"10.1016\/j.diabres.2026.113166_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2021.103916","article-title":"Ranking sets of morbidities using hypergraph centrality","volume":"122","author":"Rafferty","year":"2021","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.diabres.2026.113166_b0050","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/diacare.18.2.258","article-title":"Hyperglycemia and microvascular and macrovascular disease in diabetes","volume":"18","author":"Klein","year":"1995","journal-title":"Diabetes Care"},{"issue":"7258","key":"10.1016\/j.diabres.2026.113166_b0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Bmj-Brit Med J"},{"key":"10.1016\/j.diabres.2026.113166_b0060","unstructured":"Rafferty J, Bennett E, Lee A: multimorbidity_hypergraphs: Release v0.3.1. In.; 2021."},{"key":"10.1016\/j.diabres.2026.113166_b0065","doi-asserted-by":"crossref","DOI":"10.1023\/A:1009766219129","article-title":"The Perron-Frobenius theorem revisited","volume":"3","author":"Radjavi","year":"1999","journal-title":"Positivity"},{"issue":"6","key":"10.1016\/j.diabres.2026.113166_b0070","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/icb\/icab183","article-title":"Resolving the Rules of Robustness and Resilience in Biology across Scales","volume":"61","author":"Crespi","year":"2022","journal-title":"Integr Comp Biol"},{"issue":"11","key":"10.1016\/j.diabres.2026.113166_b0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1098\/rsif.2006.0140","article-title":"An entropic characterization of protein interaction networks and cellular robustness","volume":"3","author":"Manke","year":"2006","journal-title":"J R Soc Interface"},{"issue":"9","key":"10.1016\/j.diabres.2026.113166_b0080","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1464-5491.2012.03732.x","article-title":"Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management","volume":"29","author":"Byrne","year":"2012","journal-title":"Diabetic Med"},{"issue":"6","key":"10.1016\/j.diabres.2026.113166_b0085","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastro Hepat"},{"issue":"4","key":"10.1016\/j.diabres.2026.113166_b0090","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/hep4.1155","article-title":"Nonalcoholic fatty liver disease contributes to subclinical atherosclerosis: a systematic review and meta-analysis","volume":"2","author":"Zhou","year":"2018","journal-title":"Hepatol Commun"},{"issue":"7","key":"10.1016\/j.diabres.2026.113166_b0095","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.diabres.2026.113166_b0100","first-page":"125","article-title":"Diabetes Mellitus and Blood-Brain Barrier Dysfunction: an Overview","volume":"2","author":"Prasad","year":"2014","journal-title":"J Pharmacovigil"},{"issue":"17","key":"10.1016\/j.diabres.2026.113166_b0105","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1161\/01.CIR.0000066324.74807.95","article-title":"Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities study, 1987-1998","volume":"107","author":"Carnethon","year":"2003","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.diabres.2026.113166_b0110","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/annrheumdis-2018-213031","article-title":"Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis","volume":"77","author":"Denton","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.diabres.2026.113166_b0115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11357-019-00110-1","article-title":"Cerebral venous congestion promotes blood-brain barrier disruption and neuroinflammation, impairing cognitive function in mice","volume":"41","author":"Fulop","year":"2019","journal-title":"Geroscience"},{"key":"10.1016\/j.diabres.2026.113166_b0120","first-page":"1505","article-title":"What is an appropriate blood pressure goal for the elderly: review of recent studies and practical recommendations","volume":"8","author":"Denker","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.diabres.2026.113166_b0125","article-title":"Association between vitamin D status and cardiometabolic risk factors in adults with type 2 diabetes in Shenzhen","volume":"15","author":"Liu","year":"2024","journal-title":"China Front Endocrinol"},{"key":"10.1016\/j.diabres.2026.113166_b0130","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/580474","article-title":"The Role of Vitamin D in Diabetes and Cardiovascular Disease: an Updated Review of the Literature","volume":"2015","author":"Papandreou","year":"2015","journal-title":"Dis Markers"},{"issue":"8","key":"10.1016\/j.diabres.2026.113166_b0135","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/dc08-0545","article-title":"Translating the A1C assay into estimated average glucose values","volume":"31","author":"Nathan","year":"2008","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.diabres.2026.113166_b0140","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2026.113166_b0145","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2014revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.diabres.2026.113166_b0150","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/dc20-2439","article-title":"Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88","volume":"44","author":"Lind","year":"2021","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2026.113166_b0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.diabres.2026.113166_b0160","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.jacc.2006.02.045","article-title":"Family history of diabetes is a major determinant of endothelial function","volume":"47","author":"Goldfine","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10.1016\/j.diabres.2026.113166_b0165","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.15.4770","article-title":"Carotid lesions in outpatients with nonalcoholic fatty liver disease","volume":"15","author":"Ramilli","year":"2009","journal-title":"World J Gastroentero"},{"issue":"1","key":"10.1016\/j.diabres.2026.113166_b0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","article-title":"Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives","volume":"25","author":"Simo","year":"2014","journal-title":"Trends Endocrin Met"},{"issue":"1","key":"10.1016\/j.diabres.2026.113166_b0175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"issue":"7","key":"10.1016\/j.diabres.2026.113166_b0180","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"CV Protection in the EMPA-REG OUTCOME Trial: a \u201cThrifty Substrate\u201d Hypothesis","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2026.113166_b0185","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2026.113166_b0190","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142024. Diabetes Care, 2023, 47(Suppl 1): S158. doi: 10.2337\/dc24-S009.","DOI":"10.2337\/dc24-S009"},{"issue":"22","key":"10.1016\/j.diabres.2026.113166_b0195","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"New Engl J Med"},{"issue":"4","key":"10.1016\/j.diabres.2026.113166_b0200","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"New Engl J Med"},{"key":"10.1016\/j.diabres.2026.113166_b0205","doi-asserted-by":"crossref","unstructured":"Melanie J. Davies, Vanita R. Aroda, Billy S. Collins, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 2022, 45 (11): 2753\u20132786. doi: 10.2337\/dci22-0034.","DOI":"10.2337\/dci22-0034"},{"issue":"1 Suppl","key":"10.1016\/j.diabres.2026.113166_b0210","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2026.113166_b0215","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ijcard.2016.12.053","article-title":"Vitamin D and cardiovascular disease: from atherosclerosis to myocardial infarction and stroke","volume":"230","author":"Muscogiuri","year":"2017","journal-title":"Int J Cardiol"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726000859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:43:27Z","timestamp":1793598207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726000859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S0168822726000859"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113166","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision staging of Type 2 diabetes through Hypergraph-Based multimorbidity Profiling: From hepatic disruption to cardiovascular escalation","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113166"}}